Table 1.
Baseline demographics and clinical characteristics at diagnosis
| Characteristic | R-CEOP | R-CHOP | P |
|---|---|---|---|
| Number of patients | 70 | 140 | |
| Age, y | |||
| Median | 73 | 73 | .997 |
| Range | 34-93 | 21-92 | |
| Sex | |||
| Male | 48 (69) | 75 (54) | .037 |
| Female | 22 (31) | 65 (46) | |
| Stage | |||
| Limited | 12(17) | 20 (14) | .587 |
| Advanced | 58 (83) | 120 (86) | |
| Diagnosis | |||
| DLBCL | 66 (94) | 132 (94) | 1.00 |
| PMBCL | 0 (0) | 8 (6) | |
| IGBCL NOS | 4 (6) | 0 | |
| B-symptoms* | |||
| Yes | 31 (44) | 52 (37) | .318 |
| IPI | |||
| 0, 1 | 14 (20) | 27 (19) | 1.0 |
| 2 | 27 (39) | 55 (39) | |
| 3 | 20 (28) | 30 (22) | |
| 4, 5 | 9 (13) | 28 (20) | |
| Radiation therapy | 17 (24) | 24 (17) | .218 |
Data are presented as n (%) of patients unless otherwise indicated.
IGBCL, intermediate grade B-cell lymphoma NOS.
*
Information on B-symptoms is missing in 4 patients and 1 patient in the R-CEOP and R-CHOP group, respectively